Farnesyl Protein Transferase Inhibitor ZARNESTRA™ R115777 - History of a Discovery

E-ISSN： 1873-4294|3|10|1095-1102

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.3, Iss.10, 2003-06, pp. : 1095-1102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: A Southwest oncology group (SWOG 9924) study

By Macdonald John McCoy Sheryl Whitehead Robert Iqbal Syma Wade James Giguere Jeffrey Abbruzzese James

Investigational New Drugs, Vol. 23, Iss. 5, 2005-10 ,pp. : 485-487

Springer Publishing Company

Access to resources Recommend Favorite

Heteronemin as a Protein Farnesyl Transferase Inhibitor

By Ledroit Véronique Debitus Cécile Ausseil Frédéric Raux Roselyne Menou Jean-Louis Hill Bridget

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 42, Iss. 6, 2004-09 ,pp. : 454-456

Informa Healthcare

Access to resources Recommend Favorite

Sch-66336 (Sarasar®) and Other Benzocycloheptapyridyl Farnesyl Protein Transferase Inhibitors: Discovery, Biology and Clinical Observations

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 10, 2003-01 ,pp. : 1103-1114

Bentham Science Publishers

Access to resources Recommend Favorite

Farnesyl Protein Transferase Inhibition: A Novel Approach to Anti-tumor

Current Medicinal Chemistry, Vol. 8, Iss. 12, 2001-10 ,pp. : 1419-1436

Bentham Science Publishers

Access to resources Recommend Favorite

Tipifarnib, a farnesyl transferase inhibitor, appears to have potential for patients with locally advanced breast cancer

Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite